Whanin Pharm Co (XKRX:016580) Long-Term Capital Lease Obligation : ₩362 Mil (As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co Long-Term Capital Lease Obligation?

Whanin Pharm Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ₩362 Mil.

Whanin Pharm Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 (₩182 Mil) to Dec. 2024 (₩136 Mil) but then increased from Dec. 2024 (₩136 Mil) to Mar. 2025 (₩362 Mil).

Whanin Pharm Co's annual Long-Term Capital Lease Obligation increased from Dec. 2022 (₩64 Mil) to Dec. 2023 (₩307 Mil) but then declined from Dec. 2023 (₩307 Mil) to Dec. 2024 (₩136 Mil).

Whanin Pharm Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Whanin Pharm Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co Long-Term Capital Lease Obligation Chart

Whanin Pharm Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

1,643.22

1,305.09

63.62

307.06

135.50

Whanin Pharm Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															280.66	231.00	182.01	135.50	361.89

Whanin Pharm Co (XKRX:016580) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Whanin Pharm Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Whanin Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200

Website

http://www.whanin.co.kr

Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co Headlines

No Headlines